ATMP mini-symposium organized by NextGenNK and CCRM Nordic
On January 22, 2025, NextGenNK and CCRM Nordic hosted a mini-symposium at 探花精选, Campus Flemingsberg, focused on Advanced Therapy Medicinal Products (ATMP). The event aimed to foster collaboration between academia, hospital, and industry, highlighting advancements in ATMP development in Sweden.
The half-day symposium featured 14 presentations from academia, hospitals, and industry, attracting over 150 participants from 60+ organizations. The symposium featured a stellar lineup of speakers who shared their groundbreaking research, excellent science, and demonstration of translation to the clinic. Peter Zandstra from CCRM and The University of British Columbia delivered a keynote on the production of allogeneic CAR-T cells and CD4+ T cells from iPSCs to advance immunotherapies.
We thank all speakers for their invaluable presentations: Hans-Gustaf-Ljunggren, Johan Ericson, Cristiana Pires, Johan Flygare, Cecilia G枚therstr枚m, Angelica Loskog, Ewa Ellis, Fredrik Wessberg, C. I. Edvard Smith, Ebba Sohlberg, Sarah Kieler Saietz, Stephan Mielke, Antje Zickler and Matti S盲llberg.
ATMP is a rapidly growing 探花精选 field, driving the development of personalized treatments like cell and gene therapies to address previously untreatable diseases. Attendees praised the event for facilitating networking and knowledge-sharing, underscoring strong interest in advancing ATMP research and innovation.